Eprex: Compound Profile
Eprex 3000IU Janssen-Cilag is a recombinant human erythropoietin pharmaceutical grade preparation containing 3000 international units per vial. This glycoprotein hormone represents a standardised research tool for investigating erythropoiesis regulation, hypoxia-inducible pathways, and hematopoietic stem cell differentiation mechanisms. Manufactured by Janssen-Cilag under pharmaceutical standards, this preparation enables reproducible studies of EPO receptor signalling and cellular responses to hypoxic conditions. Research teams at Stroid UK Shop frequently examine this compound alongside other hormone preparations to understand complex endocrine interactions.
Laboratory Applications
Research laboratories utilise Eprex 3000IU preparations to study erythropoietin’s pleiotropic effects beyond red blood cell production. Investigators examine its neuroprotective properties in neural cell cultures, angiogenic responses in endothelial models, and anti-apoptotic signalling pathways. The standardised 3000IU concentration provides consistent experimental conditions for dose-response studies and mechanistic investigations. Researchers exploring comprehensive hormone interactions often investigate this preparation alongside compounds from our erythropoietin and hormone drugs category. Many studies combine EPO research with selective androgen receptor modulators to understand tissue-specific hormone responses, while others incorporate peptide research compounds to examine synergistic cellular signalling effects.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Recombinant Human Erythropoietin |
| Concentration | 3000 IU per vial |
| Manufacturer | Janssen-Cilag |
| Product Code | EU12727 |
| Molecular Weight | Approximately 30,400 Da |
| Storage | 2-8°C, protect from light |
| Solubility | Aqueous solution |
| Research Applications | Hematopoiesis, hypoxia studies, cell survival |
Research Compliance Statement
This Eprex 3000IU Janssen-Cilag preparation is supplied exclusively for in-vitro laboratory research purposes. The product is not intended for human consumption, therapeutic applications, or clinical diagnostic procedures. Research institutions must ensure appropriate handling protocols, proper storage conditions, and compliance with institutional research guidelines when studying this compound. Investigators should verify product specifications with their supplier and maintain detailed research documentation for all experimental applications involving this pharmaceutical-grade erythropoietin preparation.
